Tag: higher

Categories
Politics

Unemployment falls however is increased for Black, Hispanic employees

Unemployment falls but is higher for Black, Hispanic workers

A man hands his resume over to an employer at the 25th annual Central Florida Employment Council Job Fair on the Central Florida Fairgrounds. More than 80 companies recruited for over a thousand positions.

Paul Hennessy | LightRakete | Getty Images

Unemployment fell to 5.4% when the economy created 943,000 jobs in July, with strong increases in all population groups despite persistent labor market inequalities.

The unemployment rate for blacks and Hispanic Americans fell to 8.2% and 6.6% respectively, but the numbers are high compared to the unemployment rate for whites and Asians. Unemployment was lowest among whites at 4.8% and among Asians it fell to 5.3%.

These numbers represent a broad improvement on June when the overall unemployment rate was 5.9%. Broken down by group, it was 9.2% for blacks, 7.4% for Hispanic workers, 5.8% for Asians, and 5.2% for whites.

The total employment rate or the share of employed or jobseekers remained largely unchanged. However, it actually fell slightly among blacks, suggesting that the fall in unemployment may be partly due to some blacks dropping out of the labor market.

Still, blacks are almost as likely to be in the labor force as whites, but earn 23% less on a weekly basis at $ 799 compared to $ 1,012, according to the Bureau of Labor Statistics median wage data for the second quarter.

Hispanics, who are more labor market participants than any other demographic, earn 26% less than whites at $ 779 a week. Asians are the top earners overall, with an average weekly wage of $ 1,281.

Black and Hispanic workers are disproportionately represented in low-wage industries such as transportation and warehousing, and leisure and hospitality.

For example, black workers make up about 13% of the US workforce, but 21% of all transportation and warehouse workers. Hispanic workers make up 17% of the labor force but 24% in the leisure and hospitality industries.

The differences are even greater when one compares the wages of white men and women across the different demographic categories. White women earn 19% less, black women nearly 40% less, Hispanic women 43% less, and Asian women earn 7% less.

Asian men were the highest earners overall, with an average weekly wage of $ 1,473.

The general employment trend is moving in the right direction as the economy recovers from the pandemic, said Heidi Shierholz, former chief economist at the Department of Labor under the Obama administration.

“Because people of color were disproportionately affected by this downturn and we are recovering from it, workers of color are seeing disproportionate gains,” said Shierholz, senior economist and policy director at the liberal Economic Policy Institute.

Categories
Health

The Actual Toll From Jail Covid Circumstances Might Be Greater Than Reported

The Real Toll From Prison Covid Cases May Be Higher Than Reported

An increase in deaths across the country in the past year, past the well-known Covid-19 toll, has led health experts to suggest that some virus cases have gone undiagnosed or have been attributed to other causes. There have also been inconsistencies and changing guidelines on which deaths should be considered coronavirus deaths.

Public health officials say the prospect of missed deaths from viruses linked to the country’s prisons, jails and immigration prisons is particularly risky. It is a challenge, say the experts, to prepare prisons for future epidemics without knowing the full toll. Currently, most of the publicly known death tolls related to incarceration have come from the facilities themselves.

“You can’t make good public policy if you don’t know what’s actually going on on the ground,” said Sharon Dolovich, director of the Covid Behind Bars Data Project at the University of California at Los Angeles, which tracks coronavirus deaths in American prisons .

Prison and prison officials defended their methods of counting inmate deaths from coronavirus, saying they followed all state and local documentation requirements. Some noted that their role was to track deaths in “custody” and suggested that including the deaths of those recently in their care but no longer in their care is both complex and complex It would be impractical and possibly even overstate the number of virus cases related to the facilities.

“It is unfair to expect prisons to somehow take responsibility for what happens to people when they are released from our custody,” said Kathy Hieatt, a spokeswoman for the Virginia Beach Sheriffs Office that held Mr. Melius. “We follow law and the Virginia Department of Corrections’s extensive standards for investigating and reporting those who die in custody. In no way is it necessary to report deaths of former inmates. ”She added,“ It is absurd to think that we could somehow keep an eye on these thousands of people and take responsibility for them. ”

Throughout the pandemic, prison systems have used different methods to publicly report Covid-19-related deaths. Nevada’s prisons say they notify state health officials of inmate deaths from Covid-19 but do not make them public. Mississippi prison authorities said no inmates had died from the coronavirus at their facilities before announcing in January that nearly two dozen prisoner deaths were related to Covid-19.

Updated

July 13, 2021 at 4:53 p.m. ET

And in Texas, a prison medical committee is re-examining any case where a coroner said Covid-19 was one of the causes of death and has sometimes overridden previous findings, according to Jeremy Desel, a spokesman for the state prison system. Shelia Bradley, a 53-year-old prisoner, was reported to have died by a coroner as of “bacterial and possibly fungal pneumonia, a complication of Covid-19”, but the committee concluded that she died of “acute bacterial bronchopneumonia”. without listing Covid-19.

Categories
World News

Asia-Pacific shares edge increased; Australia central financial institution’s fee choice forward

Asia-Pacific stocks edge higher; Australia central bank's rate decision ahead

SINGAPORE — Shares in major Asia-Pacific markets edged higher on Tuesday morning as investors look ahead to the Australian central bank’s interest rate decision.

The Nikkei 225 and Topix index in Japan both rose fractionally in morning trade. Over in South Korea, the Kospi gained 0.24%.

Meanwhile, stocks in Australia climbed as the S&P/ASX 200 advanced 0.22%.

MSCI’s broadest index of Asia-Pacific shares outside Japan traded 0.08% higher.

Looking ahead, the Reserve Bank of Australia is set to announce its interest rate decision at 12:30 p.m. HK/SIN on Tuesday.

Stock picks and investing trends from CNBC Pro:

US crude futures jump

U.S. crude futures jumped in the morning of Asia trading hours on Tuesday, rising 1.57% to $76.34 per barrel. International benchmark Brent crude futures were fractionally higher at $77.19 per barrel.

Shares of Asia-Pacific firms in the oil space rose in Tuesday morning trade, with Australia’s Beach Energy rising 1.57% while Santos gained 1.44%. Shares of Inpex in Japan also jumped 1.19%.

Oil prices surged to multiyear highs on Monday after talks between OPEC and its oil-producing allies, known as OPEC+, were postponed indefinitely following a failure by the group to reach on agreement on production policy for August and beyond.

Currencies

The U.S. dollar index, which tracks the greenback against a basket of its peers, was at 92.241 — off levels above 92.4 seen late last week.

The Japanese yen traded at 110.86 per dollar after touching levels around 110.8 against the greenback yesterday. The Australian dollar changed hands at $0.7541, above levels below $0.752 seen yesterday.

Here’s a look at what’s on tap:

  • Australia: Reserve Bank of Australia’s interest rate decision at 12:30 p.m. HK/SIN

— CNBC’s Pippa Stevens contributed to this report.

Categories
Health

Gene testing agency 23andMe trades increased after Branson SPAC merger

Gene testing firm 23andMe trades higher after Branson SPAC merger

Anne Wojcicki, co-founder and CEO of 23andMe (right) celebrates with 23andMe employees after remotely ringing the NASDAQ opening bell at the headquarters of DNA technology company 23andMe in Sunnyvale, California, USA on June 17, 2021.

Peter DaSilva | Reuters

The newest trade on the exchange is “ME”.

23andMe, a personalized medicine and home genetic test kit company, went public on Thursday through a merger with a Richard Branson SPAC, VG Acquisition Corp..

23andMe stock rose 21% on the Nasdaq on its first day of trading as a publicly traded company.

Founded by Anne Wojcicki – the former wife of Google founder Sergey Brin who was an early investor in the company – 23andMe was founded 15 years ago. Together with Ancestry, it helped advance the idea that genetic testing is not just a medical field, but a big consumer business. His home test kits, which enabled people to find out their genetic profiles and ancestry by sending some saliva in the mail, ushered in a new era of personalized medicine, albeit not without controversy.

23andMe, a five-time CNBC Disruptor 50 company, had no straight or sure path to success as a publicly traded company.

It was reviewed by the FDA earlier in its history; Questions about consumer privacy continue to arise as genetic information is collected from millions of people; has run into financial difficulties in recent years when the market for personalized genetic testing seemed saturated; Skepticism about the basis of their gene-based risk analysis remains controversial; and as it delves deeper into drug development, a gap in its current customer base and underlying genetic data between a mostly European genetic profile and an underrepresentation of many minorities and ethnic groups.

“It will take time … to really make sure we get all communities to participate in the research,” Wojcicki said Thursday morning in an interview with CNBC’s TechCheck. “You can’t make discoveries in a population if those people aren’t part of it. We need the right customers and we have to present the product to them in the right way.”

Wojcicki says the company has big things ahead of it for both its consumer and drug discovery and development platforms. Approximately 80% of 23andMe’s 11 million members now choose to share their genetic information (anonymized) for drug development research.

“Our genetics represent all of life on this planet and we have the opportunity to understand what it means and, in doing so, it will improve your own life, but it will also contribute to all kinds of research discoveries,” said Wojcicki.

She says the controversy over the medical usefulness of the information won’t go away once it is put into the hands of consumers, and it ranges from critical, clinical information such as mutations in the gene that causes breast cancer, BRCA, to “more controversial” genetic ones Information on variants of Alzheimer’s disease. Some people at higher risk of blood clots choose to walk around more during flights based on their 23andMe reports.

However, she added that consumers have shown that they want this information to help them make decisions.

In the case of Alzheimer’s risk, she said, “This information … really affects how they live their lives … how they retire … plan to get older.”

Her own 10-year-old son used the company’s lactose intolerance analysis to diagnose his abdominal pain, and Wojcicki herself said, although she was reluctant to talk about her personal use of the product, as the daughter of a woman who suffered from breast cancer and who a higher risk of illness, the information influences their decision to drink that “leisure glass of wine”.

“Over the past 15 years we’ve built the infrastructure so we can take off to prove to consumers that we can get the information and understand it without a healthcare professional,” she said.

In her opinion, the key to the future is that consumers want to use the information not only to change their lives, but also to contribute to drug discovery.

23andMe has 40 programs ongoing on its drug discovery platform.

“We want them to have a truly personalized health experience and … benefit the human genome when all of this aggregated data is turned into therapeutic programs,” said Wojcicki. “When I think about the future of therapeutics, the next five years are really about moving these programs forward and getting them into the clinic.”

The company also recently launched a subscription product to bring more content and services to consumers who want to take extra steps after their genetic reports.

“We reach thousands of people who call the customer care team each week and want to know how this information can be used and applied to lead healthier longer lives,” she said.

The IPO market already set an annual record for the transaction volume of $ 171 billion in 2021, and only halfway through the year. Average first day trading profits on trades this year were over 40%. Although both the traditional IPO market and SPAC yields have cooled in recent months, the Renaissance IPO ETF and CNBC SPAC Index have been negative since the start of 2021, with a continuation of last year’s big gains since the start of the year. Meanwhile, concerns about SPAC deals have increased, and some high profile SPACs like Branson’s Virgin Galactic and electric vehicle maker Lordstown Motors have shown high levels of volatility.

Nonetheless, Branson and other investors plan to bring another space company, the satellite internet service Virgin Orbit, to the public via a SPAC in the coming weeks.

This history has been updated for the company’s closing price on the first day of trading on Thursday.

SIGN IN for our weekly original newsletter that goes beyond the list and offers a closer look at CNBC Disruptor 50’s companies and the founders who continue to innovate in all areas of the economy.

Categories
Health

CDC says coronary heart irritation in 16- to 24-year-olds increased than anticipated after second shot

CDC says heart inflammation in 16- to 24-year-olds higher than expected after second shot

A young man in West Virginia receives the vaccine while overlooking the West Virginia Capitol Building at Riggleman Hall.

Stephen Zenner | LightRakete | Getty Images

There have been a higher than expected number of cases of heart inflammation in 16- to 24-year-olds after receiving their second dose of Covid-19 vaccine from Pfizer or Moderna, the Centers for Disease Control and Prevention shared on Thursday Relying on preliminary data from its vaccine safety monitoring system.

The CDC has received reports of 275 cases in this age group as of May 31, the agency said in a presentation prepared for a meeting of the Food and Drug Administration advisory panel on Thursday. Scientists expected between 10 and 102 cases of myocarditis, or pericarditis – in which the heart muscle or the lining of the heart becomes inflamed, according to the CDC.

“We clearly have an imbalance,” said Dr. Tom Shimabukuro of the CDC’s Immunization Safety Office on Thursday on the FDA Advisory Committee on Vaccines and Related Biological Products to discuss safety issues related to the use of Covid-19 vaccines in children 6 months and older.

Although rare, a total of 475 cases of myocarditis or pericarditis have been reported in people aged 30 years and younger, according to the CDC. Most of the patients hospitalized, or 81% of them, had fully recovered from their symptoms, the agency said. May there are still 15 people in the hospital, three of them in the intensive care unit.

The majority of cases appear to occur in men, and the median time to onset of symptoms is two to three days, according to the CDC.

Some of the reported cases could be something other than myocarditis or pericarditis upon further investigation, Shimabukuro said.

The CDC’s Vaccine Safety Group announced last month that it is examining heart infections in “relatively few” people who have received Covid vaccinations.

The cases mostly affected adolescents and young adults and usually occurred within four days of the vaccination, the CDC said at the time. The condition has been seen more often in men and most cases appear to be mild, the agency said, although officials are following up on patients.

The CDC is coordinating its investigation with the FDA, which last month approved the Pfizer BioNTech vaccine for adolescents ages 12-15.

“We still don’t know if this is really related to the vaccine,” said Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, during a virtual question-and-answer event on May 27th. He added that the “handful” of reported cases were “very mild, lasting a day or two,” and usually occurred after a second dose.

Health experts say finding rare side effects once a vaccine or drug is administered to the general population, and if myocarditis is found to be related to the Covid vaccine, the risk is negligible compared to the risks of infection with Covid-19.

Categories
Health

AstraZeneca Photographs Carry Barely Larger Danger of Bleeding Drawback, New Research Says

AstraZeneca Shots Carry Slightly Higher Risk of Bleeding Problem, New Study Says

People who received the Covid vaccine, made by Oxford-AstraZeneca, were at a slightly increased risk of developing a bleeding disorder and possibly other rare blood problems, researchers reported Wednesday.

The results of a study of 2.53 million adults in Scotland who received their first dose of the AstraZeneca vaccine or the vaccine obtained from Pfizer-BioNTech were published in Nature Medicine. About 1.7 million of the shots were from the AstraZeneca vaccine.

The study found no increased risk of blood disorders with the Pfizer BioNTech vaccine.

The AstraZeneca vaccine is not approved in the United States, but it has been approved by the European Medicines Agency, the top drug agency in the European Union, as well as many countries outside the bloc. However, reports of rare coagulation and bleeding disorders in younger adults, some of which were fatal, led a number of countries to restrict the use of the vaccine to the elderly and a few to discontinue it altogether.

The new study found that the AstraZeneca vaccine was linked to a slight increase in the risk of a condition called immune thrombocytopenic purpura, or ITP, which can cause bruising in some cases but severe bleeding in others. The risk was estimated to be 1.13 cases per 100,000 people who received their first dose up to 27 days after vaccination. This estimate would be in addition to the typical pre-vaccine incidence in the UK, which has been estimated at six to nine cases per 100,000.

The condition is treatable, and none of the cases in vaccine recipients have been fatal, the researchers said. They stressed that the vaccine’s benefits far outweigh the low risk, noting that Covid itself is much more likely than the vaccine to cause ITP

However, the researchers also wrote that while the risks of the AstraZeneca vaccine are low, “alternative vaccines for those at low risk of Covid-19 may be warranted if supplies allow”.

It wasn’t surprising to find ITP in a few vaccine recipients, the researchers said, noting that the risk also increased slightly with those vaccinated against measles, mumps, and rubella, as well as those vaccinated against hepatitis B and flu.

In a comment published with the study, blood disease experts said ITP could be difficult to diagnose and that the possible association needed further analysis. But they wrote, “Still, the risk of vaccination-induced ITP appears to be far less at the suggested rate than the many risks associated with Covid-19 itself.”

The study in Scotland also found a very small increased risk of arterial clots and bleeding that may be associated with the AstraZeneca vaccine. However, the researchers said there wasn’t enough data to conclude that the vaccine has been linked to a rare type of blood clot in the brain called cerebral venous sinus thrombosis. Earlier this year, reports of these brain clots resulted in some countries suspending or restricting use of the vaccine.

The researchers said they couldn’t rule out a link to the brain clots, but there weren’t enough cases to analyze them.

The brain clots are “as rare as chicken teeth,” said Prof. Aziz Sheikh, lead author of the study from the University of Edinburgh, during a press conference.

Similar concerns have been raised about a rare condition associated with the Johnson & Johnson vaccine, which is approved in the US and other countries, particularly in younger women with brain clots and bleeding. Six U.S. cases, including one fatality, prompted federal health officials to order an interruption in use of the vaccine in April. The break was lifted after 10 days and the vaccine was reinstated with a label to warn consumers of the risk of clots and the availability of other vaccines. Several more cases were later identified and doctors were advised to avoid using heparin, a standard treatment, in these cases as it can make the condition worse.

The risk of clotting has led Denmark to reject the use of the AstraZeneca or Johnson & Johnson vaccines.

AstraZeneca and Johnson & Johnson’s vaccines both use so-called viral vectors to deliver genetic material into the recipient’s cells, and some researchers have suggested that the vectors can lead to the rare blood diseases. It is not known whether there is a connection.

The Scotland study authors said they did not know if their results on the AstraZeneca vaccine had any effect on the Johnson & Johnson vaccine, which they did not study.

Categories
World News

Shares drift larger at open, S&P 500 trades just below report

Stocks drift higher at open, S&P 500 trades just under record

The S&P 500 was just below its all-time high on Wednesday as markets continued to trade in a tight range.

The 500 stock index rose 0.2%, hitting one point off its intraday record within the first two minutes of the regular trading session. The S&P 500 is now just 0.15% below its record high of 4,238.04 May 7th. The Nasdaq Composite was up 0.5% and the Dow Jones Industrial Average held steady around Tuesday’s closing prices.

Health, communications and technology stocks drove the positive readings, with drug maker Merck up 1.8%, Twitter 1.7% and Adobe 1.5%. Fox Corp. was the best performer in the S&P 500 with a plus of 2.3%.

The meme stock mania continued Wednesday, with day traders now turning their attention to Clover Health. The stock gained another 12% before tumbling after an 85% rally on Tuesday amid explosive trading volumes. Clean Energy Fuels rose 30% on Wednesday with no apparent news.

Investors wait for the next inflation measurement to assess whether the higher price pressures are temporary as the economy continues to recover from the pandemic-induced recession.

“US stocks have been largely stuck in a range since mid-April and are unlikely to break out anytime soon,” said Edward Moya, senior market analyst at Oanda, in a press release. “Investors want to see how hot the price pressures will get and how much downtrend in stocks will happen once the Fed’s taper rage begins.”

The consumer price index for May is due to be published on Thursday. According to the Dow Jones, economists expect the consumer price index to increase by 4.7% year-on-year. In April the CPI rose 4.2% on an annual basis, the fastest increase since 2008.

Many on Wall Street believe the latest meme stock episode should be limited to a handful of names, in contrast to the GameStop trading frenzy in January that affected the broader stock market.

“Given the low risk of widespread contagion, we see the consequences of the recent short squeeze as
“Maneesh Deshpande, Global Head of Equity Derivatives Strategy at Barclays, said in a press release.” The current short squeeze is likely to be more localized because the number of stocks with high short interests has decreased dramatically.

On the data front, job vacancies rose to a new record high in April, with 9.3 million jobs posted online as the economy recovered.

– CNBC’s Tom Franck contributed to this story.

Categories
World News

Larger rates of interest can be good for the nation, Treasury Secretary Yellen says

Higher interest rates would be good for the country, Treasury Secretary Yellen says

U.S. Treasury Secretary Janet Yellen speaks during a news conference, after attending the G7 finance ministers meeting, at Winfield House in London, Britain June 5, 2021.

Justin Tallis | Rueters

U.S. Treasury Secretary Janet Yellen said that President Joe Biden’s $4 trillion spending proposal would be positive for the country, even if it leads to a rise in interest rates.

During an interview with Bloomberg News, the former Federal Reserve chair said the president’s plans would total about $400 billion each year — a level of spending she argued was not enough to create an inflation over-run.

“If we ended up with a slightly higher interest rate environment it would actually be a plus for society’s point of view and the Fed’s point of view,” Yellen told Bloomberg.

“We’ve been fighting inflation that’s too low and interest rates that are too low now for a decade,” she said. She added that if the packages help at all to “alleviate things then that’s not a bad thing — that’s a good thing.”

Read the full Bloomberg report here.

Categories
World News

Inventory futures edge greater following a rebound day on Wall Avenue

Stock futures edge higher following a rebound day on Wall Street

Traders on the floor of the New York Stock Exchange.

Source: NYSE

Stock futures rose early Friday after averages rebounded from a three-day losing streak the day before, led by technology stocks.

Futures on the Dow Jones Industrial Average showed an opening gain of around 65 points. S&P 500 futures and Nasdaq 100 futures also traded slightly higher.

The futures move followed a comeback day on Wall Street with the Dow gaining 186 points and the S&P 500 and Nasdaq Composite ending the day 1.06% and 1.77% higher, respectively. Microsoft, Facebook, and Alphabet all gained more than 1%, while Netflix and Apple each gained more than 2%.

Stocks of Tesla and other speculative parts of the market rebounded as Bitcoin prices rebounded after a roller coaster ride on Wednesday. However, Bitcoin briefly went negative after the finance department called for stricter cryptocurrency compliance with the IRS.

A new pandemic low in unemployment claims also added to the mood on Thursday. Initial unemployment benefits for the week ending May 15 stood at 444,000, the lowest since March 14, 2020, the Labor Department reported Thursday. Economists polled by Dow Jones had expected 452,000 new claims.

“Thursday’s improvement in jobless claims confirms our view that April’s disappointing job report was more of a slip than a sign of slowdown, and we expect the labor market to see significant improvement in the coming months,” he said Scott Ruesterholz, Portfolio Manager at Insight Investment.

Despite Thursday’s rebound, the Dow is down 0.9% over the past week on track to see its fourth negative week in the past five weeks. The S&P 500 is 0.4% lower from the week, in line with the pace of the second negative week in a row. The Nasdaq Composite is up 0.8% and is positioned to break a 4-week losing streak.

Home Depot shares rose 0.66% in expanded trading Thursday after the retailer announced a new $ 20 billion share buyback program. Home Depot’s announcement came after the company reported first quarter earnings and sales on Tuesday that weighed on analysts’ expectations

– CNBC’s Yun Li contributed to this report.

Categories
World News

S&P, Nasdaq 100 futures are larger after Apple & Fb beat estimates

S&P, Nasdaq 100 futures are higher after Apple & Facebook beat estimates

US stock index futures were higher early Thursday morning after major averages posted losses the previous day.

Futures contracts linked to the Dow Jones Industrial Average gained 88 points. S&P 500 futures and Nasdaq 100 futures also traded in positive territory.

The strong quarterly results from Apple and Facebook have fueled the future. Sales rose 54% for the quarter, with each product category posting double-digit growth, according to Apple. The company also announced it would increase its dividend by 7% and approved share buybacks of $ 90 billion. Facebook revenue increased 48% due to more expensive ads. Apple shares rose more than 2% in after-hours trading, while Facebook rose 6.15%.

The main averages closed in the red during normal trading. The Dow lost 165 points and lost 0.48%. The S&P 500 hit a record high but failed to sustain those gains and closed 0.08% lower. The Nasdaq Composite was down 0.28%.

The Federal Reserve said Wednesday that it would keep interest rates near zero. The S&P slid from its high after Federal Reserve Chairman Jerome Powell said during a press conference following the Federal Open Market Committee’s decision that there was some signs of froth in the market.

“Interest rates are unchanged for now, and despite the improvement in economic data, the cone talk was off the table at today’s Federal Reserve meeting,” said Bethany Payne, portfolio manager at Janus Henderson.

“As vaccination rates accelerate, employment boosts and expansive fiscal policies continue to support household and corporate incomes, investors are now looking for signs of whether the central bank’s safety net may be pulled out sooner than expected,” she added.

Thursday is the busiest day of the winning season. Around 11% of the S&P 500 is to be updated quarterly. Caterpillar, McDonald’s, Comcast, and Merck are among the names on deck before the market opens. Amazon, Gilead Sciences, Twitter, US Steel and Western Digital will publish quarterly results after the market closes.

According to Refinitiv, as of Wednesday morning, 86% of the S&P 500 components reported were above earnings estimates, with earnings 22.7% above expectations. In terms of sales, 77% of companies exceeded expectations.

The economic data released on Thursday will give investors a glimpse of the progress of the economic recovery. The first jobless claim numbers are released, with economists polled by Dow Jones expecting a pressure of 528,000. Pending home sales are also posted.

“The primary market trend remains positive,” said Keith Lerner, chief marketing strategist at Truist. “We expect a more troubled environment, however, as tensions between better economic growth and better earnings prospects versus the potential for higher taxes and rising interest rates as the economy normalizes,” he added.

Thursday marks the 100th day of President Joe Biden’s tenure. On Wednesday evening, he gave his first address to a joint congressional session where he unveiled his previously popular agenda, which included a $ 2 trillion infrastructure plan and a freshly unveiled $ 1.8 trillion plan for families, Includes children and students.

Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.
Sign in to start a free trial today